Artiva Biotherapeutics ARTV
NASDAQ ARTV
$6.36 -0.13 (-2.00%)
As of: Oct 22, 2026 · 12:24 PM EDT

Artiva Biotherapeutics (ARTV) Minority Interest (2023 - 2024)

Updated

Artiva Biotherapeutics' Minority Interest came in at $216.41 million for Q2 2024.

Analysis

Artiva Biotherapeutics (ARTV) Minority Interest (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.40 Bn 1,140.99 Bn 19.71 Bn
2 Johnson & Johnson 642.90 Bn 561.42 Bn 17.26 Bn
3 AbbVie 502.02 Bn 475.14 Bn 12.70 Bn
4 Merck 375.88 Bn 330.26 Bn 12.21 Bn
5 Novartis Ag 302.81 Bn 266.80 Bn 11.24 Bn
6 Astrazeneca 268.58 Bn 242.27 Bn 12.86 Bn
7 Amgen 242.38 Bn 197.78 Bn 7.24 Bn
8 Gilead Sciences 193.63 Bn 167.83 Bn 6.22 Bn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn
10 Artiva Biotherapeutics 251.26 Mn -98.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 216.41 Mn
Dec 31, 2023 216.41 Mn
API Access

Artiva Biotherapeutics Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=ARTV&period=max&api_key=YOUR_API_KEY